Abstract:Background: 5-hydroxytryptophan (5-HTP), the direct biosynthetic precursor of the neurotransmitter 5-hydroxytryptamine, has been shown to have unique efficacy in the treatment of a variety of disorders, including depression, insomnia, and chronic headaches, and is one of the most commercially valuable amino acid derivatives. However, microbial fermentation for 5-HTP production continues to face many challenges, including low titer/yield and the presence of the intermediate L-tryptophan (L-Trp), owing to the complexity and low activity of heterologous expression in prokaryotes. Therefore, there is a need to construct an efficient microbial cell factory for 5-HTP production. Results: We describe the systematic modular engineering of wild-type Escherichia coli for the efficient fermentation of 5-HTP from glucose. First, a xylose-induced T7 RNA polymerase-PT7 promoter system was constructed to ensure the efficient expression of each key heterologous pathway in E. coli. Next, a new tryptophan hydroxylase mutant was used to construct an efficient tryptophan hydroxylation module, and the cofactor tetrahydrobiopterin synthesis and regeneration pathway was expressed in combination. The L-Trp synthesis module was constructed by modifying the key metabolic nodes of tryptophan biosynthesis, and the heterologous synthesis of 5-HTP was achieved. Finally, the NAD(P)H regeneration module was constructed by the moderate expression of the heterologous GDHesi pathway, which successfully reduced the surplus of the intermediate L-Trp. The final engineered strain HTP11 was able to produce 8.58 g/L 5-HTP in a 5-L bioreactor with a yield of 0.095 g/g glucose and a maximum real-time productivity of 0.48 g/L/h, the highest values reported by microbial fermentation. Conclusion: In this study, we demonstrate the successful design of a cell factory for high-level 5-HTP production, combined with simple processes that have potential for use in industrial applications in the future. Thus, this study provides a reference for the production of high-value amino acid derivatives using a systematic modular engineering strategy and a basis for an efficient engineered strain development of 5-HTP high-value derivatives.

Directed evolution and metabolic engineering generate an Escherichia coli cell factory for de novo production of 4-hydroxymandelate

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine

Metabolic engineering of Escherichia coli for de novo production of 5-hydroxyvalerate via L-lysine α-oxidase pathway

Production of l-phenylalanine from glucose by metabolic engineering of wild type Escherichia coli W3110

Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol

Metabolic engineering of Escherichia coli for the efficient production of 5-hydroxyvaleric acid

[Metabolic engineering of Escherichia coli for de novo synthesis of 1,4-butanediol]

Metabolic Engineering of Escherichia coli for High-Level Production of l-Phenylalanine

De novo Synthesis of 2-phenylethanol from Glucose by Metabolically Engineered Escherichia coli

Engineering Escherichia coli for production of geraniol by systematic synthetic biology approaches and laboratory-evolved fusion tags

Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose

Multiple Metabolic Engineering Strategies to Improve Shikimate Titer in Escherichia coli

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

[Metabolic engineering study on biosynthesis of 4-hydroxybenzyl alcohol from L-tyrosine in Escherichia coli]

Balancing the AspC and AspA Pathways of Escherichia coli by Systematic Metabolic Engineering Strategy for High-Efficient l-Homoserine Production

Metabolic engineering of Escherichia coli for efficient production of 1,4-butanediol from crude glycerol

Metabolic Engineering of a Homoserine-Derived Non-Natural Pathway for the De Novo Production of 1,3-Propanediol from Glucose

Genetic and Bioprocess Engineering for the Selective and High-Level Production of Geranyl Acetate in Escherichia coli

Genetic engineering of an industrial yeast Candida glycerinogenes for efficient production of 2-phenylethanol

Biosensor-assisted evolution for high-level production of 4-hydroxyphenylacetic acid in Escherichia coli

Metabolic Engineering of Escherichia coli for De Novo Production of 1,5-Pentanediol from Glucose